Validation of a new prognostic body composition parameter in cancer patients.
Paolo Pedrazzoli(Policlinico San Matteo Fondazione), Emanuele Cereda(GTx (United States)), N. Stobäus(Humboldt-Universität zu Berlin), Annalisa Turri(Policlinico San Matteo Fondazione), Andrea Riccardo Filippi(University of Turin), Marilisa Caraccia(Policlinico San Matteo Fondazione), Silvia Brugnatelli(Policlinico San Matteo Fondazione), Daniela Cicognini(University of Pavia), Riccardo Caccialanza(University of Pavia), Simona Secondino(Azienda Ospedaliera Treviglio), Ilaria Imarisio(University of Pavia), Catherine Klersy(Policlinico San Matteo Fondazione), Teresa Monaco(Istituti di Ricovero e Cura a Carattere Scientifico), Atonello Giannoni(Accademia di Belle Arti di Carrara), Kristina Norman(University of Potsdam)
Cited by 0
Related Papers
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
ESPEN guideline clinical nutrition in neurology
|Clinical Nutrition|2017|533
Nutritional status in older persons according to healthcare setting: A systematic review and meta-analysis of prevalence data using MNA ®
|Clinical Nutrition|2016|487
Survival and dementia in <scp> <i>GBA</i> </scp> ‐associated Parkinson's disease: <scp>T</scp> he mutation matters
|Annals of Neurology|2016|408